InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Explore the full record of transactions filed by Lowdell Mark William, Directeur Scientifique. Director active across 1 companies, notably Inmune Bio, Inc.. Cumulatively, 9 reports have been recorded. Total volume traded: €318k. The latest transaction was filed on 22 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€180,50323,590 shares@ €7.65170.44% mcap36.2% of flow
Common Stock
SEC:0001213900-22-014509:0·
€12,108701 shares@ €17.2727.6% of flow
Common Stock
SEC:0001213900-21-056740·
€12,108701 shares@ €17.2720.029% mcap2.4% of flow
Common Stock
SEC:0001213900-21-056740:0·
€40,6382,357 shares@ €17.241225.6% of flow
Common Stock
SEC:0001213900-21-055421·
€40,6382,357 shares@ €17.24120.099% mcap8.2% of flow
Common Stock
SEC:0001213900-21-055421:0·
€6,882400 shares@ €17.20384.3% of flow
Common Stock
SEC:0001213900-21-054642·
€6,882400 shares@ €17.20380.017% mcap1.4% of flow
Common Stock
SEC:0001213900-21-054642:0·
€99,3075,850 shares@ €16.975662.5% of flow
Common Stock
SEC:0001213900-21-036355·
€99,3075,850 shares@ €16.97560.24% mcap19.9% of flow
Common Stock
SEC:0001213900-21-036355:0·
9 of 9 declarations
About Lowdell Mark William
Mark William Lowdell is the Chief Scientific Officer at Inmune Bio, Inc. In this role, he is responsible for leading the company's research and development initiatives. Mark William Lowdell plays a key role in innovation and scientific advancement within the organization. His expertise in biotechnology and life sciences is essential for supporting Inmune Bio's research objectives. He collaborates with multidisciplinary teams to develop innovative therapeutic solutions.
